Coronavirus Update: Merck’s COVID antiviral may be linked to virus mutations, study finds

Molnupiravir, which was granted an emergency use authorization by the FDA in December 2021, may allow mutated viruses to spread, a study has found.

Previous post The first tour inside Manhattan’s newest private club, with $100,000 membership fees
Next post The Ratings Game: These 20 growth stocks are worth considering on a pullback, says Citi